Calvin Goforth, PhD

Calvin Goforth, PhD
Calvin Goforth, PhD, VIC Founder and Chief Executive Officer, has extensive experience in start-up company development in founder, investor, board member, and executive roles. His experience encompasses intellectual property assessment, building strong development teams, raising private investment and government funding, and bringing products to market. He received a BS in Aerospace Engineering with Highest Honors from the University of Texas at Austin.
Find me on:

Recent Posts

Why VIC Sometimes Steps Outside Its Life Science Focus

VIC Technology Venture Development primarily is focused on building companies around high-impact life science technologies, including medical devices, therapeutics, diagnostics, and advanced instrumentation. More than...

VIC 2019 Annual Report

In the past year, VIC’s portfolio of companies reached numerous milestones, the VIC Investor Network (VIN) experienced its first exit, and we added important new elements to the VIC ecosystem. While progress in 2019 was...

A Letter from our CEO

Welcome to the 20s! To my ears, 2020 sounds very futuristic – but we are living it. The pace of technological change continues to accelerate and have profound impact on all of us. VIC’s motto is Technology Solutions for...

White Paper: Avoiding Herd Mentality - Sourcing Quality Innovation Beyond The VC Hot Zones

Twenty years ago, a two-bedroom apartment in the heart of Silicon Valley would cost an entrepreneur $1,600 a month1. Today, the same apartment would go for $4,000 per month or more. The cost of living and doing business...

Expanded VIC Investor Network (VIN)

VIC Investor Network Impact healthcare investing for accredited individuals   What is the VIC Investor Network? The VIC Investor Network (“VIN”) makes investments into companies that are based on technologies that can...

FEATURED RESOURCES

News
VIC Technology Venture Development Forms New Portfolio Company: Neurexis Therapeutics
Reports
VIC 2019 Annual Report
White Paper
Accessing Innovation Directly from the Source - Growing Trends in Venture Capital Company Formation
News
VIC Portfolio Companies and Pipeline Technologies with Pandemic Impact
Interview
An Interview with Nichole Mercier at Washington University
White Paper
Sourcing Quality Innovation Beyond the VC Hot Zones
Case Study
Behind the Curtain: Opportunity Assessment at VIC Technology Venture Development
White Paper
New Paradigms of Life Science Investing
Interview
Behind the Curtain with Biolocity | Guiding Medical Innovations to Market
News
VIC Technology Venture Development Forms New Portfolio Company: Filtravate
White Paper
Life Science Impact Investing and the Physician Entrepreneur
From The Corner Office
SFC Fluidics Nears FDA Submission